Dalian BIO-CHEM's low P/E ratio is due to its three-year growth being lower than market forecast. Investors think the potential for earnings improvement doesn't justify a higher P/E ratio. Unless medium-term conditions improve, they will continue to form a barrier for the share price.
百傲化學股票討論區
暫無評論